Issues

Journal & Issues

AHEAD OF PRINT

Volume 11 (2021): Issue 2 (December 2021)

Volume 11 (2021): Issue 1 (December 2021)

Volume 10 (2020): Issue 1 (December 2020)

Volume 9 (2019): Issue 2 (December 2019)

Volume 9 (2019): Issue 1 (December 2019)

Volume 8 (2018): Issue 2 (December 2018)

Volume 8 (2018): Issue 1 (June 2018)

Volume 7 (2017): Issue 2 (December 2017)

Volume 7 (2017): Issue 1 (June 2017)

Volume 6 (2016): Issue 2 (December 2016)

Volume 6 (2016): Issue 1 (June 2016)

Volume 5 (2015): Issue 2 (December 2015)

Volume 5 (2016): Issue 1 (June 2016)

Volume 4 (2014): Issue 2 (December 2014)

Volume 4 (2014): Issue 1 (June 2014)

Volume 3 (2013): Issue 2 (December 2013)

Volume 3 (2013): Issue 1 (June 2013)

Volume 2 (2012): Issue 2 (December 2012)

Volume 2 (2012): Issue 1 (June 2012)

Volume 1 (2011): Issue 2 (December 2011)

Volume 1 (2011): Issue 1 (June 2011)

Journal Details
Format
Journal
eISSN
2084-1264
First Published
09 Apr 2014
Publication timeframe
2 times per year
Languages
English

Search

AHEAD OF PRINT

Journal Details
Format
Journal
eISSN
2084-1264
First Published
09 Apr 2014
Publication timeframe
2 times per year
Languages
English

Search

2 Articles
Open Access

When Science Races: the Standard of Care and Medical Negligence in the Times of Covid-19

Published Online: 28 Sep 2022
Page range: -

Abstract

Abstract

When a new disease emerges, there are at first no specific medicinal products to treat it. This has also been the case in the Covid-19 pandemic. Scientists and health professionals have been trying to establish the best treatments possible using the already-existing medicines that are normally used for different indications. The off-label use of medicinal products is a standard part of medical practice. If it meets certain criteria, it is not contradictory to the standard of care. Nevertheless, the urgency of the pandemic situation brings about new issues. What amount of data on efficacy and safety should be considered sufficient to scientifically justify the off-label use of a particular medicine? How should health professionals reflect the rapid scientific developments and high levels of uncertainty in their clinical practice? How can be these factors influenced by the politicisation of medicine? The paper deals with the outlined questions in order to analyse and concretise the criteria for off-label use of medicinal product in the specific context of the Covid-19 pandemic.

Keywords

  • health law
  • standard of care
  • medical negligence
  • off-label use of medicinal products
  • Covid-19
  • tort law
Open Access

Medical Liability for Allocation of Scarce Healthcare Resources in the COVID-19 Pandemic: the Italian scenario

Published Online: 05 Jan 2023
Page range: -

Abstract

Abstract Summary

1. Tragic Choices in COVID times; 2. Criteria for the Allocation of Scarce Healthcare Resources; 3. Liability of Healthcare Professionals and Institutions; 4. Possible solutions?

Keywords

  • Medical liability
  • covid-19
  • resource allocation
2 Articles
Open Access

When Science Races: the Standard of Care and Medical Negligence in the Times of Covid-19

Published Online: 28 Sep 2022
Page range: -

Abstract

Abstract

When a new disease emerges, there are at first no specific medicinal products to treat it. This has also been the case in the Covid-19 pandemic. Scientists and health professionals have been trying to establish the best treatments possible using the already-existing medicines that are normally used for different indications. The off-label use of medicinal products is a standard part of medical practice. If it meets certain criteria, it is not contradictory to the standard of care. Nevertheless, the urgency of the pandemic situation brings about new issues. What amount of data on efficacy and safety should be considered sufficient to scientifically justify the off-label use of a particular medicine? How should health professionals reflect the rapid scientific developments and high levels of uncertainty in their clinical practice? How can be these factors influenced by the politicisation of medicine? The paper deals with the outlined questions in order to analyse and concretise the criteria for off-label use of medicinal product in the specific context of the Covid-19 pandemic.

Keywords

  • health law
  • standard of care
  • medical negligence
  • off-label use of medicinal products
  • Covid-19
  • tort law
Open Access

Medical Liability for Allocation of Scarce Healthcare Resources in the COVID-19 Pandemic: the Italian scenario

Published Online: 05 Jan 2023
Page range: -

Abstract

Abstract Summary

1. Tragic Choices in COVID times; 2. Criteria for the Allocation of Scarce Healthcare Resources; 3. Liability of Healthcare Professionals and Institutions; 4. Possible solutions?

Keywords

  • Medical liability
  • covid-19
  • resource allocation

Plan your remote conference with Sciendo